Cytosol Vascular Endothelial Growth Factor in Endometrial Carcinoma: Correlation with Disease-Free Survival
- 1 February 2001
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 80 (2) , 207-212
- https://doi.org/10.1006/gyno.2000.6048
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- HER-2/neu, P53, and DNA analyses as prognosticators for survival in endometrial carcinomaPublished by Wolters Kluwer Health ,2002
- Serum Vascular Endothelial Growth Factor in Epithelial Ovarian Neoplasms: Correlation with Patient SurvivalGynecologic Oncology, 1999
- Vascular endothelial growth factor in cervical carcinomaPublished by Wolters Kluwer Health ,1999
- Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinomaCancer, 1999
- Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survivalAmerican Journal of Obstetrics and Gynecology, 1998
- Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survivalInternational Journal of Cancer, 1997
- Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospectsJournal of Molecular Medicine, 1995
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast CancerJapanese Journal of Cancer Research, 1994
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990